SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 31, 2007	View HTML 0001144204-07-039148.pdf 0001144204-07-039148.rtf 0001144204-07-039148.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 31, 2007	View HTML 0001144204-07-039162.pdf 0001144204-07-039162.rtf 0001144204-07-039162.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 19, 2007	View HTML 0001144204-07-037239.pdf 0001144204-07-037239.rtf 0001144204-07-037239.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 18, 2007	View HTML 0001144204-07-037102.pdf 0001144204-07-037102.rtf 0001144204-07-037102.xls
SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	Jul 17, 2007	View HTML 0000078003-07-000180.pdf 0000078003-07-000180.rtf 0000078003-07-000180.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 16, 2007	View HTML 0001144204-07-036647.pdf 0001144204-07-036647.rtf 0001144204-07-036647.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 06, 2007	View HTML 0001144204-07-035458.pdf 0001144204-07-035458.rtf 0001144204-07-035458.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 06, 2007	View HTML 0001144204-07-035479.pdf 0001144204-07-035479.rtf 0001144204-07-035479.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Jul 02, 2007	View HTML 0001144204-07-034576.pdf 0001144204-07-034576.rtf 0001144204-07-034576.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Jul 02, 2007	View HTML 0001144204-07-034580.pdf 0001144204-07-034580.rtf 0001144204-07-034580.xls

Data provided by Kaleidoscope.